The immunoregulatory function of vitamin D: implications in chronic kidney disease (Q38012025)

27 August 2017

The immunoregulatory function of vitamin D: implications in chronic kidney disease (English)

1 reference

27 August 2017

0 references

3

1 reference

27 August 2017

Kevin A Sterling

1

1 reference

27 August 2017

Parham Eftekhari

series ordinal

2

1 reference

27 August 2017

Paul L Kimmel

series ordinal

4

1 reference

27 August 2017

Dominic S Raj

series ordinal

5

1 reference

27 August 2017

language of work or name

English

0 references

publication date

22 May 2012

1 reference

Nature Reviews Nephrology

27 August 2017

1 reference

27 August 2017

8

1 reference

27 August 2017

403-412

1 reference

27 August 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2012.93

27 August 2017

0 references

cites work

Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Temporal trends in the prevalence of diabetic kidney disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Chronic kidney disease and mortality risk: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Immunologic function and survival in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Aspects of immune dysfunction in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Bacterial infections in hemodialysis patients: pathogenesis and prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Immune mechanisms involved in cardiovascular complications of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Immunological basis of inflammation in dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

The noncalciotropic actions of vitamin D: recent clinical developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Vitamin D and the immune system: role in protection against bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Vitamin D and the immune system: new perspectives on an old theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Vitamin D and immune function: understanding common pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Vitamin D signaling in immune-mediated disorders: Evolving insights and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

21 January 2018

Vitamin D: metabolism

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Studies on calciferol metabolism. VII. The renal production of the biologically active form of vitamin D, 1,25-dihydroxycholecalciferol; species, tissue and subcellular distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Regulation of vitamin D metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Specific regulation of CYP27B1 and VDR in proximal versus distal renal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Tumor Necrosis Factor-α Regulation of 1,25-Dihydroxy vitamin D Production by Human Keratinocytes*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Vitamin D: a pleiotropic hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Renoprotective effects of vitamin D analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Use of vitamin D in chronic kidney disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

New vitamin D analogs and changing therapeutic paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Association of oral calcitriol with improved survival in nondialyzed CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Toll-like receptors in human infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

TLR2 and TLR4 expression during bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Skeletal muscle, cytokines, and oxidative stress in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Cytokine gene polymorphism and progression of renal and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Haemodialysis induces mitochondrial dysfunction and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Neutrophil dysfunction and infection risk in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Vitamin D in African Americans with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Regulation of target gene expression by the vitamin D receptor - an update on mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a randomized, placebo-controlled study to evaluate the post-transplant outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Toll-like receptors on the fork roads between innate and adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Cod-liver Oil in Phthisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Innate antimicrobial peptide protects the skin from invasive bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

LL-37, the only human member of the cathelicidin family of antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

The roles of cathelicidin LL-37 in immune defences and novel clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Immunomodulating effects of vitamin D analogs in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

1 alpha,25-dihydroxyvitamin D3 suppresses interleukin-1beta-induced interleukin-8 production in human whole blood: an involvement of erythrocytes in the inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Nonclassic actions of vitamin D

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Regulatory T cells and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

The role of vitamin D deficiency in sepsis and potential therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Epidemiology of sepsis in Germany: results from a national prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Prevalence and correlates of vitamin D deficiency in US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Regulation of TNF-alpha by 1alpha,25-dihydroxyvitamin D3 in human macrophages from CAPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

1,25-dihydroxyvitamin D(3) dose-dependently inhibits LPS-induced cytokines production in PBMC modulating intracellular calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Signaling danger: toll-like receptors and their potential roles in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Vitamin D levels and early mortality among incident hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Immunomodulation by 1,25-dihydroxyvitamin D3: therapeutic implications in hemodialysis and renal transplantation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Enhanced production rate of 1,25-dihydroxyvitamin D in sarcoidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Vitamin D and the heart: why we need large-scale clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Mortality risk among hemodialysis patients receiving different vitamin D analogs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

1,25-Dihydroxyvitamin D3Receptors in Human Leukocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Intravenous calcitriol therapy restores reduced antigen-induced T-lymphocyte response in 1,25-(OH)2D3-deficient hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Calcitriol effect on natural killer cells from hemodialyzed and normal subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Vitamin D therapy modulates cytokine secretion in patients with renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

1,25-Dihydroxyvitamin D3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

On the vascular inotropic action of 1,25-(OH)2 vitamin D3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Effect of 1,25-dihydroxy-vitamin D3 in experimental sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Zinc balance in combined zinc deficiency and uremia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Zinc modulates mononuclear cellular calcitriol metabolism in peritoneal dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Risk factors for peritoneal dialysis-associated peritonitis: the role of oral active vitamin d

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.93

Immunological effects of zinc deficiency in sickle cell anemia (SCA).

31 March 2020

1 reference

12 December 2020

Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models

1 reference

12 December 2020

Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes

1 reference

12 December 2020

Effects of oral paricalcitol on hyperparathyroidism and proteinuria in peritoneal dialysis patients

1 reference

12 December 2020

Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol

1 reference

12 December 2020

Alterations in plasma levels and complexing of Gc (vitamin D-binding protein) in rats with endotoxic shock.

1 reference

12 December 2020

Immunomodulatory effects of 1,25-dihydroxyvitamin D3.

1 reference

12 December 2020

1,25(OH)2D response to combined zinc and phosphorus depletion in rats

1 reference

12 December 2020

Not enough vitamin D: health consequences for Canadians

1 reference

12 December 2020

Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages

1 reference

12 December 2020

1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro

1 reference

12 December 2020

1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation

1 reference

12 December 2020

Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review

1 reference

12 December 2020

Determinants of soluble CD23 antigen levels in hemodialysis patients: effect of 1.25 dihydroxyvitamin D3 and recombinant human erythropoietin treatment

1 reference

12 December 2020

In vivo effect of 1 alpha-hydroxyvitamin D3 on interleukin-2 production in hemodialysis patients

1 reference

12 December 2020

The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis

1 reference

12 December 2020

A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and -4 expression in peripheral blood monocytes of hemodialysis patients.

1 reference

12 December 2020

Zinc nutritional status modulates the 1,25-(OH)2D. Response in uremic rats

1 reference

12 December 2020

Low concentrations of serum 25-hydroxyvitamin D associated with increased risk for chronic bronchitis among US adults

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2012.93

1 reference

27 August 2017

1 reference